Is Arcutis a good investment?
As of 2025-03-24, the Fair Value of Arcutis Biotherapeutics Inc (ARQT) is -5.90 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 17.01 USD, the upside of Arcutis Biotherapeutics Inc is -134.70%. This means that Arcutis is not a good investment.
Note: valuation result may not be accurate due to the low predictability of business.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -135.68 | -206.36 | -311.46 | -262.14 | -140.04 | -211.14 |
| YoY growth | -223.05% | -52.09% | -50.93% | 15.84% | 46.58% | -52.73% |
| Market Cap (mil) | 2,018.07 |
| P/E | |
| Forward P/E |
| EPS | -1.16 |
| Avg earnings growth rate | -52.73% |
| TTM earnings |